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Abstract
C12H17N3S, monoclinic, P21/c (no. 14), a= 9.3084(19) Å,
b= 7.9523(16) Å, c= 16.905(3) Å, β= 92.26(3)°, V =
1250.4(4) Å3, Z = 4, Rgt(F)=0.0330, wRref(F2)=0.0914,
T = 100(2) K.
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The molecular structure is shown in the figure. Table 1
contains crystallographic data and Table 2 contains the list
of the atoms including atomic coordinates and displacement
parameters.
Table 1: Data collection and handling.
Crystal: Colourless prism
Size: 0.24×0.10×0.06 mm
Wavelength: Cu Kα radiation (1.5418 Å)
µ: 2.11 mm−1
Diffractometer, scan mode: Oxford Diffraction Gemini, ω
θmax, completeness: 71.3°, >99%
N(hkl)measured, N(hkl)unique, Rint: 13212, 2413, 0.024
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 2215
N(param)refined: 153




(Acros Organic), absolute ethanol (Merck), acetonitrile
(Merck) and ethyl acetate (Merck)were of analytical grade and
used as purchased. 4-Methyl-3-thiosemicabazide (1.0516 g,
0.01 mol) was dissolved in hot absolute ethanol (20 mL) and
then 4-phenylbutanone (1.50 mL, 0.01 mol)was added slowly
while stirring andheating (348 K) for about 20 min. Thewhite
precipitate was filtered, washed with cold ethanol and dried
in vacuo then dissolved in a mixture of acetonitrile and ethyl
acetate (2:1 v/v). Single crystals were grown at room temper-
ature by the slow evaporation of the solution. Yield: 89%.
M. Pt 368–369 K. FT-IR (ATR (solid) cm−1): 3133 ν(Ar C–
H), 3317 ν(N–H), 3000 ν(=C–H), 2754 ν(C–H), 1602 ν(C=N),
1239 ν(N–N), 1058 ν(C=S). 1H-NMR (500 MHz, CDCl3, ppm):
δ 8.45 (s, 1H, S=CN(H)N), 7.35 (s, 1H, S=CN(H)N), 7.27–7.30
(m, 2H, H9, H11), 7.21 (d, 1H, J = 7.3 Hz, H10), 7.18 (d, 2H,
J = 7.6 Hz, H8, H12), 3.17 (d, 3H, J = 4.7 Hz, H2), 2.87 (t, 2H,
J = 7.7 Hz, H6), 2.60 (t, 2H, J = 7.7 Hz, H5), 1.87 (s, 3H, H4).
13C{1H} NMR (125 MHz, CDCl3, ppm): δ 178.9 (C1), 151.0 (C3),
140.9 (C7), 128.6 (C8, C12), 128.2 (C9, C11), 126.2 (C10), 40.0
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Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
S1 0.71062(3) 0.93907(4) 0.45494(2) 0.01953(13)
N1 0.79356(12) 0.74224(15) 0.57708(7) 0.0207(3)
H1N 0.7656(18) 0.6735(18) 0.6128(8) 0.025*
N2 0.55323(12) 0.74931(14) 0.54609(7) 0.0185(2)
H2N 0.4810(13) 0.8089(18) 0.5283(9) 0.022*
N3 0.54024(12) 0.64202(14) 0.61034(6) 0.0185(2)
C1 0.68733(14) 0.80478(16) 0.53119(8) 0.0170(3)
C2 0.94563(14) 0.7699(2) 0.56540(9) 0.0262(3)
H2A 0.974316 0.708782 0.518231 0.039*
H2B 1.001822 0.729295 0.611779 0.039*
H2C 0.963258 0.890389 0.558321 0.039*
C3 0.42008(14) 0.56576(16) 0.61675(8) 0.0185(3)
C4 0.29254(14) 0.58452(18) 0.56022(9) 0.0246(3)
H4A 0.249036 0.695496 0.567167 0.037*
H4B 0.221728 0.497014 0.570858 0.037*
H4C 0.323643 0.573290 0.505761 0.037*
C5 0.40771(15) 0.44824(18) 0.68564(9) 0.0226(3)
H5A 0.393302 0.332837 0.664835 0.027*
H5B 0.320696 0.478875 0.714244 0.027*
C6 0.53605(16) 0.44630(18) 0.74498(8) 0.0228(3)
H6A 0.548857 0.561366 0.766472 0.027*
H6B 0.511901 0.372266 0.789624 0.027*
C7 0.67865(15) 0.38873(17) 0.71409(8) 0.0206(3)
C8 0.80552(16) 0.46118(19) 0.74471(8) 0.0257(3)
H8 0.800468 0.545411 0.784353 0.031*
C9 0.93906(17) 0.4131(2) 0.71859(9) 0.0294(3)
H9 1.023973 0.464014 0.740454 0.035*
C10 0.94842(16) 0.2906(2) 0.66059(9) 0.0276(3)
H10 1.039316 0.257960 0.642048 0.033*
C11 0.82313(17) 0.21648(19) 0.62999(9) 0.0271(3)
H11 0.828584 0.131930 0.590523 0.032*
C12 0.68985(16) 0.26466(17) 0.65652(8) 0.0234(3)
H12 0.605243 0.212271 0.635093 0.028*
(C5), 32.4 (C2), 31.1 (C6), 16.0 (C4). GC-MS(EI): m/z calcd. for
C12H17N3S+ = [M+]= 235, found 235.
Experimental details
The C-bound H atoms were geometrically placed
(C—H=0.95–0.98 Å) and refined as riding with U iso(H)=
1.2–1.5Ueq(C). The N-bound H atoms were refined with
N—H=0.88±0.01 Å, and with U iso(H)= 1.2Ueq(N).
Comment
Thiosemicarbazone derivatives, i.e. molecules with general
formula RN(H)C(=S)N(H)N=CR′, have been known for well
over a century [5]. The 1,2-di-substituted thiourea deriva-
tives can be readily prepared from the reaction of thiosemi-
carbazide, H2NC(=S)NHNH2, with an aldehyde or ketone.
Two thiosemicarbazone drugs, Methisazone and Thioaceta-
zone, are among those which have been used in the past.
Methisazone, an anti-viral drug, is produced by the con-
densation of N-methylisatin with thiosemicarbazide and
has recently been studied for repurposing for the treat-
ment of COVID-19 [6]. Although the use of thioaceta-
zone, H2NC(=S)N(H)N=CC6H4-4-N(H)C(=O)CH3, is no longer
recommended, there has been interest in some of its deriva-
tives [7] to be employed against Mycobacterium tuberculo-
sis. Metal complexes of thiosemicarbazones are also known
to possess biological activity [8] and that is a key motiva-
tion for on-going studies in this area [9, 10]. With this in
mind, the synthesis of a thiosemicarbazone derivative was
attempted and herein, the crystal andmolecular structures of
MeN(H)C(=S)N(H)N=C(H)CH2CH2Ph, (I), are described.
The molecular structure of (I) is shown in the figure
(70% displacement ellipsoids) and adopts a distinctive,
U-shape conformation. This is evidenced in the sequence of
C1—N2—N3—C3 [−167.97(12)°], N2—N3—C3—C5 [179.13(11)°],
N3—C3—C5—C6 [5.73(18)°] andC3—C5—C6—C7 [−62.76(16) Å]
torsion angles with a dramatic twist about the C3—C5 bond.
The stabilisation of this arrangement comes about, at least
in part, due to the formation of an intramolecular amine-
N—H· · · π(phenyl) [N1—H1n· · ·Cg(C6—C11):=H1n· · ·Cg(C6—
C11)= 2.970(14) Å with angle at H1n= 145.1(13)°] interaction.
It is also noted that this same N—H atom participates in an
intramolecular hydrogen bond with the imine-N atom [N1—
H1n· · ·N3: H1n· · ·N3= 2.111(17) Å, N1—N3= 2.5722(17) Å
with angle at H1n= 112.9(13)°] indicating this atom may
be considered bifurcated. The C1, N1, N2 and S1 atoms
comprising the chromophore are strictly planar, exhibit-
ing a r.m.s. deviation of 0.0086 Å, with the appended N3
and C2 atoms lying 0.0393(18) and 0.143(3) Å to either side
of this plane. The conformation about the imine C3=N3
[1.2807(18) Å] is E, and the thioamide-N—H and -S atoms
are syn.
In the only other crystallographically characterised
thiosemicarbazone structure with an ethylene link between
the imine and phenyl residues, i.e. differing only from (I) by
having a methoxy group in the 4-position of the phenyl ring
[11], themolecule is flat in the–CH2CH2– region (all-trans) and
is approximately co-planar with the C=NN(H)C(=S)N(H)Me
residue. It is also of interest to compare the structure of (I)
with that of the unsaturated derivative, i.e. with a C5=C6
double-bond [12]. By contrast to (I), this adopts, to a first
approximation, a planar structure.
The key feature of the molecular packing in the crys-
tal of (I) is the formation of centrosymmetric dimers via
amide-N—H· · · S(thione) hydrogen bonds [N2—H2n· · · S1i:
H2n· · · S1i = 2.705(13) Å, N2· · · S1i = 3.4885(14) Å with angle
at H2n= 151.0(13)° for symmetry operation (i) 1− x, 2− y,
1− z] leading to an eight-membered {· · ·HNCS}2 syn-
thon, which has a flattened chair conformation. The only
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other directional interactions noted in the crystal are
of the type methylene-C—H· · ·N(imine) [C6—H6b· · ·N3ii:
H6b· · ·N3ii = 2.55 Å, C6· · ·N3ii = 3.5325(19) Å with angle
at H6b= 171° for (ii) 1− x, −1/2+ y, 3/2− z]. These con-
nect the dimeric aggregates into a supramolecular layer in
the bc-plane; the planes stack without directional interac-
tions between them. This observation prompted a further
investigation of the molecular packing by the calculation
of the Hirshfeld surfaces and the full and delineated two-
dimensional fingerprint plots with the use of Crystal Explorer
17 [13] and established procedures [14].
Despite the fingerprint plot delineated into H· · · S/S· · ·H
contacts showing characteristic sharp spikes ascribed to the
N—H· · · S hydrogen bonds, the total contribution to the cal-
culated Hirshfeld surface is 16.3%, i.e. considerably less than
contributed by H· · ·H contacts, at 62.2%. The only other two
significant contributions to the surface are fromH· · ·C/C· · ·H
[14.0%] and H· · ·N/N· · ·H [7.3%] contacts.
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